Janine Santora
Nurse Practitioner · Pennington, NJNPI 1972154110
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 41.8% of the total. Reporting peaked in 2021 at $13,798 and has fallen 75.8% since, to $3,342 in 2025. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $105.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$8K
- AbbVie$6K
- Boston Scientific$2K
- Biogen$693
- Eisai Inc.$680
- Biohaven Pharmaceutical Holding Company Ltd.$452
- plus $2K from 15 others
What the payments were for
- Consulting fees$5203%
- Speaking & faculty fees$12,05559%
- Travel & lodging$2,72013%
- Food & beverage$4,86624%
- Education$1381%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 18 | $8,478 |
| AbbVie(2 entities) | 78 | $6,210 |
| Boston Scientific | 10 | $1,830 |
| Biogen | 20 | $693 |
| Eisai Inc. | 5 | $680 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $452 |
| Axsome Therapeutics, Inc. | 9 | $310 |
| AstraZeneca | 5 | $271 |
| Lilly USA, LLC | 3 | $262 |
| Pfizer | 22 | $217 |
| Neurocrine Biosciences, Inc. | 4 | $174 |
| Amgen(2 entities) | 2 | $139 |
| Teva Pharmaceuticals USA, Inc. | 3 | $138 |
| Impel Pharmaceuticals Inc. | 4 | $133 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Novo Nordisk | 1 | $101 |
| Johnson & Johnson | 2 | $27 |
| Genentech USA, Inc. | 1 | $21 |
| UCB, Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Aprecia Pharmaceuticals, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,299 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 17 | $105,663 |
| AptiomEslicarbazepine Acetate | 28 | $34,781 |
| QuliptaAtogepant | 29 | $30,842 |
| Nurtec OdtRimegepant Sulfate | 15 | $14,845 |
| UbrelvyUbrogepant | 11 | $11,256 |
| Lacosamide | 29 | $6,821 |
| Levetiracetam | 125 | $4,177 |
| Memantine Hcl | 161 | $3,951 |
| Memantine Hcl ErMemantine Hcl | 12 | $1,840 |
| Topiramate | 107 | $1,614 |
| Carbamazepine ErCarbamazepine | 20 | $1,526 |
| Donepezil Hcl | 88 | $1,439 |
| Oxcarbazepine | 21 | $1,344 |
| RivastigmineRivastigmine Tartrate | 27 | $1,039 |
| Atorvastatin Calcium | 69 | $913 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $138 | $105,66317 claims |
| AbbVieQulipta, Ubrelvy | $6,210 | $42,09840 claims |
| PfizerNurtec Odt | $217 | $14,84515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Pennington
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.